Parachuting in the epigenome: The biology of gene vector insertion profiles in the context of clinical trials

EMBO Molecular Medicine

Volumn 3, Issue 2, 2011, Pages 75-77

  Baum, Christopher ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Gene therapy; Retroviral vector

Indexed keywords

ADENOSINE DEAMINASE; RETROVIRUS VECTOR;

ADENOSINE DEAMINASE DEFICIENCY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN STRUCTURE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL TRIAL (TOPIC); EPIGENETICS; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENE VECTOR; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; INSERTIONAL MUTAGENESIS; MURINE LEUKEMIA VIRUS; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; VIRAL GENE THERAPY; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; WISKOTT ALDRICH SYNDROME;

ADENOSINE DEAMINASE; CHROMATIN; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION PROFILING; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HISTONES; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; RETROVIRIDAE; SEVERE COMBINED IMMUNODEFICIENCY; VIRUS INTEGRATION;

EID: 79551522229     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201000110     Document Type: Article

References (6)

1. Aiuti A, et al (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360: 447- 458
2. Biasco L, et al (2011) EMBO Mol Med 3: 89- 101
3. Cattoglio C, et al (2010) High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood 116: 5507- 5517
4. Colin L, Van Lint C (2009) Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6: 111
5. Kustikova O, et al (2010) The genomic risk of somatic gene therapy. Semin Cancer Biol 20: 269- 278
6. Shen X, Orkin SH (2009) Glimpses of the epigenetic landscape. Cell Stem Cell 4: 1- 2